| Market Cap | ₹1,22,539Cr |
| ROE | 16.53% |
| P/E Ratio(TTM) | 22.55 |
| EPS(TTM) | 67.27 |
| P/B Ratio | 3.72 |
| Dividend Yield | 1.05% |
| Industry P/E | 33.07 |
| Book Value | 407.53 |
| Debt to Equity | 0.01 |
| Face Value | 2 |
| Parent Organisation | Cipla Limited |
| Managing Director | Mr Umang Vohra |
| Founded | 1935 |
| NSE Symbol | CIPLA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.93 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.60 | ||
| Lupin | NA (0.00%) | 22.34 | ||
| Zydus Lifesciences | NA (0.00%) | 18.40 |